Changeflow GovPing Pharma & Drug Safety EP4127152A1 - Methods for Identifying Genomic D...
Routine Notice Added Final

EP4127152A1 - Methods for Identifying Genomic DNA Bound to Protein

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

EPO published patent application EP4127152A1 for Altius Institute for Biomedical Sciences and The Brigham & Women's Hospital, Inc. The invention covers methods, compositions, and kits for identifying regions of genomic DNA bound to a protein. The application was published under the A1 publication kind code on April 8, 2026.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

EPO published patent application EP4127152A1 for methods, compositions, and kits for identifying regions of genomic DNA bound to a protein. The application names Altius Institute For Biomedical Sciences and The Brigham & Women's Hospital, Inc. as applicants, with John A. Stamatoyannopoulos and Andrew B. Stergachis as inventors.

Affected parties including biotechnology researchers, pharmaceutical companies, and genomic research institutions may review this publication for freedom-to-operate assessments or potential licensing opportunities. The designated states cover all relevant European Patent Convention member states including AT, BE, CH, DE, DK, ES, FI, FR, GB, IE, IT, NL, NO, and SE.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

METHODS, COMPOSITIONS, AND KITS FOR IDENTIFYING REGIONS OF GENOMIC DNA BOUND TO A PROTEIN

Publication EP4127152A1 Kind: A1 Apr 08, 2026

Applicants

Altius Institute For Biomedical Sciences, The Brigham & Women's Hospital, Inc.

Inventors

STAMATOYANNOPOULOS, John A., STERGACHIS, Andrew B.

IPC Classifications

C12Q 1/6806 20180101AFI20240327BHEP C12N 9/10 20060101ALI20240327BHEP C12N 9/22 20060101ALI20240327BHEP C12N 15/09 20060101ALI20240327BHEP C12Q 1/68 20180101ALI20240327BHEP C40B 30/00 20060101ALI20240327BHEP C40B 30/04 20060101ALI20240327BHEP G01N 1/28 20060101ALI20240327BHEP C12Q 1/6869 20180101ALI20240327BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4127152A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers Research institutions
Industry sector
3254.1 Biotechnology 3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Patent publication Genomic research methods Biotech IP
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!